This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
  • Pre-Assessment
  • Activity
  • Post-Test
  • Evaluation
  • Claim Credit
Updates in Atopic Dermatitis for the Rural Primary Care Clinician

Updates in Atopic Dermatitis for the Rural Primary Care Clinician

Format

Webcast

Time to Complete

1 hour

Released

June 4, 2019

Expires

June 4, 2020
Add to Queue


Maximum Credits

1.00 / AMA PRA Category 1 CreditTM
1.00 / ANCC Contact Hour (0.30 pharmacotherapeutic contact hours)

Accredited Provider

This enduring activity is jointly provided by RME Collaborative and University of Nebraska Medical Center.

Commercial Supporter

This activity is supported by an educational grant from Sanofi Genzyme and Regeneron Pharmaceuticals.

Program Description

Atopic dermatitis is a common inflammatory skin disease, but it is often underrecognized and undertreated leading to significant morbidity, poor quality of life, and high health care costs. In rural and underserved communities where access to specialty care and follow-up is challenging, the impact of this skin disease may be significant given that symptoms are often inadequately controlled on standard treatments and can persist throughout a patient’s lifetime. In this CME/CE activity, expert faculty will discuss best practices in patient evaluation, the latest information on the treatment of moderate to severe atopic dermatitis, and strategies for improving care in rural and underserved areas.

Intended Audience

This activity is designed specifically for primary care clinicians and nurses practicing in rural and underserved areas.

Educational Objectives

After completing the activity, the participant should be better able to:

  • Describe the pathophysiology and immunologic factors associated with atopic dermatitis.
  • Summarize safety and efficacy data of new and emerging targeted therapies for moderate to severe atopic dermatitis.
  • Implement strategies to improve atopic dermatitis management in the rural primary care setting.

Conflicts of Interest Disclosure Policy

As a provider accredited by ACCME, the University of Nebraska Medical Center, Center for Continuing Education, the University of Nebraska Medical Center, College of Nursing Continuing Nursing Education, and the American Nurses Credentialing Center’s Commission on Accreditation must ensure balance, objectivity, independence, and scientific rigor in its educational activities. Faculty are encouraged to provide a balanced view of therapeutic options by utilizing either generic names or the trade names of several to ensure impartiality.

All speaker, planning committee members, and others in a position to control continuing medical education content participating in a University of Nebraska Medical Center, Center for Continuing Education, University of Nebraska Medical Center, College of Nursing Continuing Nursing Education, and American Nurses Credentialing Center’s Commission on Accreditation activity are required to disclose relationships with commercial interests. A commercial interest is any entity producing, marketing, reselling, or distributing health care goods or services consumed by, or used on, patients. Disclosure of these commitments and/or relationships is included in these course materials so that participants in the activity may formulate their own judgments in interpreting its content and evaluating its recommendations.

This activity may include presentations in which faculty may discuss off-label and/or investigational use of pharmaceuticals or instruments not yet FDA-approved. Participants should note that the use of products outside currently FDA-approved labeling should be considered experimental and are advised to consult current prescribing information for FDA-approved indications.

All materials are included with the permission of the authors. The opinions expressed are those of the
authors and are not to be construed as those of the University of Nebraska Medical Center, Center for Continuing Education, University of Nebraska Medical Center, College of Nursing Continuing Nursing Education, or American Nurses Credentialing Center’s Commission on Accreditation.

The following indicates the disclosure declaration information and the nature of those commercial relationships.

Faculty

Peter A. Lio, MD (Program Chair)
Clinical Assistant Professor of Dermatology & Pediatrics
Northwestern University Feinberg School of Medicine
Director, Chicago Integrative Eczema Center
Founding Partner, Medical Dermatology Associates of Chicago
Chicago, IL

Dr. Lio has disclosed the following relationships: consultant for AbbieVie, Inc., Eli Lilly and Company, Exeltis, Franklin BioScience, Galderma Laboratories, L.P., Heel (Biologische Heilmittel Heel GmbH), Johnson & Johnson Consumer Products Company, Kiniksa Pharmaceuticals, Ltd., L’Oreal USA Inc., Odeza LLC, Theraplex, Unilever, and Valeant Pharmaceuticals International; advisory board for Altus Labs, Anacor Pharmaceuticals Inc, DermTap, Inc., DermVeda, gpower, inc. IntraDerm Pharmaceuticals, Johnson & Johnson Consumer Products Company, Menlo Therapeutics, Realm Therapeutics, Regeneron Pharmaceuticals, Inc., Sanofi US Services, Syncere Skin Systems, UCB, Modernizing Medicine, and National Eczema Association; speaker for Ferndale Laboratories Inc., Galderma Laboratories, L.P., Johnson & Johnson Consumer Products Company, La Roche-Posay Laboratorie Pharmaceutique, Mission, Pfizer Inc., Pierre Fabre Dermatologie, Regeneron Pharmaceuticals, Inc., and Valeant Pharmaceuticals North America LLC; grant/research support from AOBiome, LLC and La Fondation pour la Dermatite Atopique (Foundation for Atopic Dermatitis); and stockholder in Modernizing Medicine.

Elizabeth A. Kiracofe, MD
Board-Certified Dermatologist
Illinois Dermatology Institute
Chicago, IL

Dr. Kiracofe has no relevant financial conflicts to disclose.

Accredited Provider Disclosure

The following planning committee members for this activity have no conflicts to disclose:

Heidi Keeler, PhD, RN, Director, Continuing Nursing Education, College of Nursing, UNMC
Justin G. Madson, MD, PhD, FAAD, Peer Reviewer, Midwest Dermatology Clinic, PC
Renee Paulin, MSN, RN, CWOCN, Nurse Planner, Continuing Nursing Education, College of Nursing, UNMC
Brenda Ram, CMP, CHCP, Interim Director, Educational Programs, Center for Continuing Education, UNMC
Kristin Della Volpe, Medical Writer, Scientific Affairs, Talem Health, LLC
Erica Rusie, PharmD, Scientific Director, Scientific Affairs, Talem Health, LLC

Credit

1.00

Type

AMA PRA Category 1 Credit(s)TM

Accreditation Statement

The University of Nebraska Medical Center, Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the University of Nebraska Medical Center, Center for Continuing Education and RME Collaborative.

Designation Statement

The University of Nebraska Medical Center, Center for Continuing Education designates this enduring material for a maximum of 1.00 AMA PRA Category 1 CreditTM  .  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Credit

1.00

Type

CNE Contact Hour(s)

Accreditation Statement

The University of Nebraska Medical Center College of Nursing Continuing Nursing Education is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Nurses Credentialing Center’s Commission on Accreditation (ANCC) through the joint providership of the University of Nebraska Medical Center College of Nursing Continuing Nursing Education (UNMC CON CNE) and RME Collaborative.

Designation Statement

This activity is provided for 1.00 contact hour under ANCC criteria.

This activity is provided for 0.30 contact hours related to pharmacotherapeutic content.

Disclosure of Unlabeled Use

No product purposes other than those approved by the FDA will be discussed.

Disclaimer

The University of Nebraska Medical Center and RME Collaborative present this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. The University of Nebraska Medical Center and RME Collaborative assume no liability for the information herein.

Instructions

To obtain credit, a score of 75% or better on the post-test is required. This activity is offered at no cost to participants. Please proceed with the activity until you have successfully completed this activity, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your credit certificate. Your online certificate will be saved on myCME within your Profile/Exam History, which you can access at any time.

If you have any questions relating to the accreditation of this activity, please contact Anji Heath, at anjella.heath@unmc.edu.

SYSTEM REQUIREMENTS

Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Add to Queue